Chemoinformaics analysis of 4-hydroxycitrulline
Molecular Weight | 191.187 | nRot | 5 |
Heavy Atom Molecular Weight | 178.083 | nRig | 2 |
Exact Molecular Weight | 191.091 | nRing | 0 |
Solubility: LogS | -0.578 | nHRing | 0 |
Solubility: LogP | -3.47 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 25.1963 |
nHD | 5 | BPOL | 14.2077 |
QED | 0.336 |
Synth | 3.262 |
Natural Product Likeliness | 0.59 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.825 |
HIA | 0.021 |
CACO-2 | -6.405 |
MDCK | 0.00309577 |
BBB | 0.586 |
PPB | 0.0675527 |
VDSS | 0.361 |
FU | 0.910452 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.019 |
CYP2c19-inh | 0.045 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.056 |
CYP2c9-sub | 0.081 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.202 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.01 |
CL | 3.796 |
T12 | 0.501 |
hERG | 0.016 |
Ames | 0.054 |
ROA | 0.012 |
SkinSen | 0.154 |
Carcinogencity | 0.013 |
EI | 0.036 |
Respiratory | 0.12 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.862379 |